FM

Frazier Management Portfolio holdings

AUM $1.12M
This Quarter Return
+2.02%
1 Year Return
+150.24%
3 Year Return
+430.4%
5 Year Return
+1,926.83%
10 Year Return
–
AUM
$882M
AUM Growth
+$882M
Cap. Flow
+$330M
Cap. Flow %
37.37%
Top 10 Hldgs %
91.23%
Holding
26
New
6
Increased
1
Reduced
4
Closed
1

Top Buys

1
ARQT icon
Arcutis Biotherapeutics
ARQT
$314M
2
PASG icon
Passage Bio
PASG
$78.9M
3
SNDX icon
Syndax Pharmaceuticals
SNDX
$10.9M
4
ADVM icon
Adverum Biotechnologies
ADVM
$9.87M
5
TRIL
Trillium Therapeutics Inc.
TRIL
$9.55M

Top Sells

1
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
$77.7M
2
COLL icon
Collegium Pharmaceutical
COLL
$15.4M
3
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
$4.46M
4
ETTX
Entasis Therapeutics Holdings Inc.
ETTX
$793K
5
KZR icon
Kezar Life Sciences
KZR
$363K

Sector Composition

1 Healthcare 98.92%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ARQT icon
1
Arcutis Biotherapeutics
ARQT
$1.86B
$314M 35.62% +10,542,790 New +$314M
PHAT icon
2
Phathom Pharmaceuticals
PHAT
$864M
$188M 21.33% 7,284,269 – –
PASG icon
3
Passage Bio
PASG
$22.7M
$78.9M 8.95% +5,009,219 New +$78.9M
IOVA icon
4
Iovance Biotherapeutics
IOVA
$807M
$52.4M 5.94% 1,750,665 – –
MIRM icon
5
Mirum Pharmaceuticals
MIRM
$3.71B
$49.9M 5.66% 3,566,912 – –
KRYS icon
6
Krystal Biotech
KRYS
$4.27B
$38.7M 4.39% 895,000 – –
ANAB icon
7
AnaptysBio
ANAB
$569M
$32.7M 3.71% 2,316,447 – –
TBIO
8
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$21.8M 2.47% 2,182,789 – –
COLL icon
9
Collegium Pharmaceutical
COLL
$1.22B
$15.4M 1.75% 943,666 -943,666 -50% -$15.4M
ADVM icon
10
Adverum Biotechnologies
ADVM
$64.6M
$12.5M 1.42% 1,278,328 +1,009,985 +376% +$9.87M
GRTS
11
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$12M 1.36% 2,061,758 – –
SNDX icon
12
Syndax Pharmaceuticals
SNDX
$1.41B
$10.9M 1.23% +990,711 New +$10.9M
TRIL
13
DELISTED
Trillium Therapeutics Inc.
TRIL
$9.55M 1.08% +2,443,809 New +$9.55M
ALPN
14
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$7.41M 0.84% 2,571,450 – –
TPST icon
15
Tempest Therapeutics
TPST
$44M
$7.37M 0.84% 1,396,615 – –
APTX
16
DELISTED
Aptinyx Inc. Common Stock
APTX
$6.89M 0.78% 3,190,079 – –
ITRM icon
17
Iterum Therapeutics
ITRM
$30.2M
$4.17M 0.47% 1,538,316 – –
CDTX icon
18
Cidara Therapeutics
CDTX
$1.66B
$3.25M 0.37% 1,312,258 – –
ALNA
19
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
$3.21M 0.36% 3,330,373 – –
RCKT icon
20
Rocket Pharmaceuticals
RCKT
$354M
$2.93M 0.33% +210,000 New +$2.93M
ETTX
21
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$2.78M 0.31% 1,049,953 -300,000 -22% -$793K
NBRV
22
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$2.45M 0.28% 4,256,526 – –
VTVT icon
23
vTv Therapeutics
VTVT
$2.03M 0.23% +1,062,000 New +$2.03M
SRRA
24
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$1.99M 0.23% 202,803 -7,909,318 -98% -$77.7M
BLCM
25
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$495K 0.06% 105,144 -946,297 -90% -$4.46M
1
2